Results 91 to 100 of about 1,497 (161)

Long-term recombinant human growth hormone therapy in Dent’s disease type 1

open access: yesEndokrynologia Polska
Not required for Clinical Vignette.
Miao Huang   +5 more
doaj   +1 more source

Dent’s disease: case series from a single center

open access: yesThe Turkish Journal of Pediatrics
Background. Dent’s disease (DD) is a rare X-linked recessive tubulopathy characterized by low molecular weight proteinuria, hypercalciuria, nephrocalcinosis/nephrolithiasis and chronic kidney disease.
Hilal Yaşar   +5 more
doaj   +1 more source

A sibling with Dent disease without mutations of OCRL1 and CLCN5

open access: yesNihon Shoni Jinzobyo Gakkai Zasshi, 2011
Kimata, Takahisa   +5 more
openaire   +2 more sources

Genetic Screening of Patients With Inherited Fanconi Syndrome. [PDF]

open access: yesKidney Int Rep
Inoki Y   +24 more
europepmc   +1 more source

Molecular Basis of Rare Inherited Tubulopathies of the Kidney: A Primer for Clinicians. [PDF]

open access: yesInt J Mol Sci
Vecino-Pérez M   +4 more
europepmc   +1 more source

Bioinformatics analysis of a <i>CLCN5</i> geneframeshift mutation in a patient with Dent disease. [PDF]

open access: yesZhong Nan Da Xue Xue Bao Yi Xue Ban
Zhang Y, Li N, Fan L, Liu J.
europepmc   +1 more source

Home - About - Disclaimer - Privacy